2026
$2.24
▼
Recomputed on current basis (prior row used CFO - total capex - SBC with no working-capital removal; superseded). OE = CFO - dWC - SBC - maintenance capex + non-cash litigation accrual adjustment. CFO=$1,545M; dWC (sum of cash-flow working-capital lines: AR -32, AP -48, accrued comp +8, contract liabilities +74, income taxes payable -96, other assets +16, other liabilities -364; Instacash held-for-sale -205 is offset by the matching non-cash 'loss on sale of Instacash' add-back of +205 and is treated as neither) = $(442)M; SBC=$237M; capex=$22M, capex_ratio=1.461% (10-yr mean FY17-26), growth capex=1.461% x (5,000-3,935)=$15.6M (revenue growth is mostly acquired MoneyLion), maintenance capex=$6.4M; litigation: other liabilities includes the $354M non-cash reversal of the Columbia patent accrual (reduced to $254M) which is non-recurring and is re-charged (-$354M) because the accrual was added to OE when booked in FY22-FY25. OE = 1,545 + 442 - 237 - 6.4 - 354 = $1,389.6M; diluted shares 619M; OE/sh=$2.2448. Cash interest paid $626M. Note FY26 is a 53-week year. Source: FY2026 10-K, accession 0000849399-26-000017.
2025
$1.86
▼
Recomputed on current basis (prior row omitted working-capital removal; superseded). OE = CFO - dWC - SBC - maintenance capex + non-cash litigation accrual. CFO=$1,221M; dWC = AR -53 + AP 26 + accrued comp 27 + contract liabilities 36 + income taxes payable -80 + other assets 86 + other liabilities -114 = $(72)M; SBC=$133M; capex=$15M, capex_ratio 1.461%, growth capex=1.461% x (3,935-3,800)=$2.0M, maintenance capex=$13.0M; Columbia patent accrual rose $583M->$598M (+$15M non-cash, inside other liabilities) added back. OE = 1,221 + 72 - 133 - 13.0 + 15 = $1,162.0M; diluted shares 624M; OE/sh=$1.8621. Cash interest paid $557M. Source: FY2025 10-K, accession 0000849399-25-000033 (unchanged in 0000849399-26-000017).
2024
$0.78
▼
Recomputed on current basis (prior row omitted working-capital removal; superseded). OE = CFO - dWC - SBC - maintenance capex + non-cash litigation accrual. CFO=$2,064M; dWC = AR 7 + AP -12 + accrued comp -24 + contract liabilities 47 + income taxes payable 446 + other assets 861 + other liabilities 432 = $1,757M (dominated by the $899M fiscal-2023 tax refund collected in Q4 and the reversal of the FY23 tax receivable build); SBC=$138M; capex=$20M, capex_ratio 1.461%, growth capex=1.461% x (3,800-3,317)=$7.1M, maintenance capex=$12.9M; Columbia patent accrual rose $237M->$583M (+$346M non-cash after the Sept-2023 judgment, inside other liabilities) added back. OE = 2,064 - 1,757 - 138 - 12.9 + 346 = $502.1M; diluted shares 642M; OE/sh=$0.7820. Year is depressed by a -$991M deferred tax item tied to the FY2023 tax-receivable swing; FY23 and FY24 should be read together (average ~$1,066M). Cash interest paid $607M. Source: FY2024 10-K 0000849399-24-000036; restated net income $607M per 0000849399-25-000033.
2023
$2.61
▼
Recomputed on current basis (prior row omitted working-capital removal; superseded). OE = CFO - dWC - SBC - maintenance capex + non-cash litigation accrual. CFO=$757M; dWC = AR 11 + AP -8 + accrued comp -6 + contract liabilities 16 + income taxes payable -128 + other assets -702 + other liabilities -137 = $(954)M (other assets includes build of the ~$899M tax refund receivable collected in FY24); SBC=$134M; capex=$6M, capex_ratio 1.461%, growth capex=1.461% x (3,317-2,796)=$7.6M, maintenance capex=$0; Columbia accrual rose $185M->$237M (+$52M) added back. OE = 757 + 954 - 134 - 0 + 52 = $1,629.0M; diluted shares 624M; OE/sh=$2.6106. Includes Avast from Sept 12, 2022. Read together with FY24 (average ~$1,066M) because the tax receivable/refund swing straddles both years. Cash interest paid $390M. Source: FY2023 10-K 0000849399-23-000014; restated revenue/net income per 0000849399-25-000033.
2022
$1.59
▼
Recomputed on current basis (prior row omitted working-capital removal; superseded). OE = CFO - dWC - SBC - maintenance capex + non-cash litigation accrual. CFO=$974M; dWC = AR -9 + AP 10 + accrued comp -26 + contract liabilities 67 + income taxes payable -78 + other assets -7 + other liabilities 190 = $147M; SBC=$70M; capex=$6M, capex_ratio 1.461%, growth capex=1.461% x (2,796-2,551)=$3.6M, maintenance capex=$2.4M; Columbia jury verdict accrual of $185M (non-cash, inside other liabilities) added back. OE = 974 - 147 - 70 - 2.4 + 185 = $939.6M; diluted shares 591M; OE/sh=$1.5898. Standalone NortonLifeLock pre-Avast. Note: CFO also excludes $355M property sale proceeds (investing) and the $175M gain is a non-cash deduction already netted in CFO. Cash interest paid $120M. Source: FY2022 10-K, accession 0000849399-22-000013.
2021
$1.31
▼
OE = CFO - dWC - SBC - maintenance capex. CFO=$706M; dWC = AR 3 + AP -44 + accrued comp -10 + contract liabilities 118 + income taxes payable -299 + other assets 144 + other liabilities -79 = $(167)M; SBC=$81M; capex=$6M, capex_ratio 1.461% (10-yr mean), growth capex=1.461% x (2,551-2,490)=$0.9M, maintenance capex=$5.1M. OE = 706 + 167 - 81 - 5.1 = $786.9M; diluted shares 600M; OE/sh=$1.3115. First full year as standalone NortonLifeLock consumer business after the Nov-2019 sale of the enterprise business to Broadcom. Cash interest paid $139M. Source: FY2021 10-K 0000849399-21-000010 (values as repeated in 0000849399-22-000013).
2020
-$2.72
▼
OE = CFO - dWC - SBC - maintenance capex. CFO=$(861)M; dWC = AR 583 + AP -61 + accrued comp -117 + contract liabilities -121 + income taxes payable 383 + other assets -81 + other liabilities -101 = $485M; SBC=$312M; capex=$89M, revenue fell (2,490 vs 4,731 restated basis) so growth capex=0, maintenance capex=$89M. OE = -861 - 485 - 312 - 89 = $(1,747)M; diluted shares 643M; OE/sh=$(2.7170). NON-REPRESENTATIVE: CFO is depressed by ~$1,985M of cash income taxes, mostly on the $10.9B Broadcom enterprise divestiture gain whose proceeds sit in investing; enterprise business included for ~7 months. Excluded from the anchor. Cash interest paid $179M. Source: FY2020 10-K 0000849399-20-000004 (values as repeated in 0000849399-22-000013).
2019
$0.71
▼
OE = CFO - dWC - SBC - maintenance capex. CFO=$1,495M; dWC = AR 113 + AP 6 + accrued comp 2 + contract liabilities 215 + income taxes payable 67 + other assets -32 + other liabilities 114 = $485M; SBC=$352M; capex=$207M, revenue declined (4,731 vs 4,834) so growth capex=0, maintenance capex=$207M. OE = 1,495 - 485 - 352 - 207 = $451.0M; diluted shares 661M per original filing, 632M as later restated (632M used); OE/sh=$0.7136. Symantec Corp including the enterprise security business later sold to Broadcom - a different business; excluded from the anchor. Cash interest paid $183M. Source: FY2019 10-K, accession 0000849399-19-000005.
2018
-$1.08
▼
OE = CFO - dWC - SBC - maintenance capex. CFO=$950M; dWC = AR -170 + AP -4 + accrued comp -33 + contract liabilities 541 + income taxes payable 880 + other assets -199 + other liabilities -86 = $929M (income taxes payable includes the US tax reform transition tax accrual); SBC=$610M; capex=$142M, capex_ratio 1.461%, growth capex=1.461% x (4,834-4,019)=$11.9M, maintenance capex=$130.1M. OE = 950 - 929 - 610 - 130.1 = $(719.1)M; diluted shares 668M; OE/sh=$(1.0765). Symantec Corp with enterprise business and post-Blue Coat/LifeLock integration - a different business; excluded from the anchor. Cash interest paid $199M. Source: FY2019 10-K 0000849399-19-000005 (FY2018 column).
2017
$0.07
▼
OE = CFO - dWC - SBC - maintenance capex. CFO=$(209)M (total incl. discontinued); dWC = AR 45 + AP -67 + accrued comp 20 + contract liabilities 125 + income taxes payable -871 + other assets 84 + other liabilities -90 = $(754)M (tax payments on the Veritas divestiture gain); SBC=$440M; capex=$70M, capex_ratio 1.461%, growth capex=1.461% x (4,019-3,600)=$6.1M, maintenance capex=$63.9M. OE = -209 + 754 - 440 - 63.9 = $41.1M; diluted shares 618M; OE/sh=$0.0665. Symantec Corp year of Blue Coat and LifeLock acquisitions - a different business; excluded from the anchor. Cash interest paid $143M. Source: FY2019 10-K 0000849399-19-000005 (FY2017 column) and FY2017 10-K 0000849399-17-000009.
Owner's earnings per share by fiscal year, most recent first. Tap a row to see how that figure was calculated, including the source filing.